Danshen (Salvia Miltiorrhiza)
A traditional Chinese root used for angina and circulation. Hundreds of Chinese trials look positive, but they are of poor methodological quality, and the one rigorous Western trial found nothing.
Evidence last reviewed: August 2026
What the science says
- Angina pectoris Limited evidence
A meta-analysis of 109 randomised trials with 11,973 participants found danshen dripping pills better than isosorbide dinitrate for symptoms and ECG changes (odds ratios around 2.4–2.9), but the authors judged the risk of bias high for randomisation and blinding across almost all included studies, and the comparator was an active drug rather than placebo.
- Cardiovascular risk factors Limited evidence
A randomised, double-blind crossover trial in 20 hyperlipidaemic, hypertensive adults in the Netherlands found danshen root water extract had no beneficial effect on blood pressure, endothelial function or lipids, and LDL was slightly higher on danshen than placebo.
- Circulation and blood flow Limited evidence
Much of the Chinese evidence comes from intravenous danshen injections given in hospital, which say nothing about what an oral capsule does; oral supplement data are sparse.
Dosage & safety
Scientific references
- How Efficacious is Danshen (Salvia miltiorrhiza) Dripping Pill in Treating Angina Pectoris? Evidence Assessment for Meta-Analysis of Randomized Controlled Trials
- Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Heart & metabolic
- Vitamin B3 (Niacin) Limited evidence
- Vitamin K2 (MK-7) Limited evidence
- Chromium Limited evidence
- Potassium Strong evidence
- Vanadium Limited evidence
- L-Arginine Moderate evidence